Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

HIV-Associated Diffuse Large B-Cell Lymphoma Shows Different Genomic Patterns between EBV-Positive and EBV-Negative Tumors

Blood (2024) 144 (Supplement 1): 2976.

https://doi.org/10.1182/blood-2024-206279

Published: 2024

Journal Articles

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Blood (2014) 124 (21): 722.

https://doi.org/10.1182/blood.V124.21.722.722

Published: 2014

Journal Articles

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Kristin A Rand, PhD, M.P.H., Chi Song, M.S., Amie E. Hwang, PhD, M.P.H., Carol A. Huff, MD, Leon Bernal-Mizrachi, MD, Michael H Tomasson, MD, Sikander Ailawadhi, MD, David J. Van Den Berg, PhD, Xin Sheng, PhD, John J. Graff, PhD, M.S., David V. Conti, PhD, Todd Zimmerman, MD, Edward Peters, D.MD S.M, Sc.D., Seema Singhal, MD, Cathryn H. Bock, PhD, Karen Pawlish, M.P.H., Graham A Colditz, MD, Dr.PH., Xin Sheng, PhD, Alexander Stram, M.S., Sara S. Strom, PhD, Benjamin Rybicki, PhD, Rick Kittles, PhD, Howard Terebelo, DO, Janet Stanford, PhD, MPH, Phyllis J. Goodman, PhD, Sonja I Berndt, PhD, John Carpten, PhD, Anselm JM Hennis, MSc,PhD MRCP, FRCP, Lisa Chu, PhD, M.P.H., Graham Casey, PhD, W R Driver, MSPH, Eric A. Klein, MD, M. Christina Leske, MD MPH, Esther John, PhD, Adam Bryant Murphy, MD, Christine Neslund-Dudas, PhD, Victoria L. Stevens, PhD, Curtis Pettaway, MD, Wei Zheng, MD PhD MPH, Suh-Yuh Wu, M.A., John Witte, PhD, Siqun Lilly Zheng, MD, Jianfeng Xu, MD,Dr.PH, Nikhil C. Munshi, MD, Ann Hsing, PhD, Sue Ingles, PhD, Jayesh Mehta, MD, Lisa B. Signorello, PhD, Stephen Jacob Chanock, MD, Barbara Nemesure, PhD, Ann M Mohrbacher, MD, Nalini Janakiraman, MD, William J Blot, MD, Brian E. Henderson, MD, Laurence N. Kolonel, MD PhD, Kenneth C. Anderson, MD, Brian C-H Chiu, PhD, Jeffrey Zonder, MD, Robert Z. Orlowski, PhD MD, Sagar Lonial, MD, Daniel O. Stram, PhD, Christopher Haiman, Sc.D., Wendy Cozen, DO, MPH

Blood (2014) 124 (21): 2030.

https://doi.org/10.1182/blood.V124.21.2030.2030

Published: 2014

Journal Articles

High Throughput Sequencing-Based Pathogen Discovery In Multiple Myeloma

Akinyemi I. Ojesina, MBBS, PhD, Chandra Sekhar Pedamallu, PhD, Aleksandar Kostic, PhD, Joonil Jung, PhD, Daniel Auclair, PhD, Jens Lohr, MD, PhD, John Carpten, PhD, Gad Getz, Ph.D., Jonathan J Keats, PhD, Matthew Meyerson, MD, PhD

Blood (2013) 122 (21): 5322.

https://doi.org/10.1182/blood.V122.21.5322.5322

Published: 2013

Journal Articles

Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles

Blood (2013) 122 (21): 532.

https://doi.org/10.1182/blood.V122.21.532.532

Published: 2013

Journal Articles

Gene Expression Profiling Of Multiple Myeloma Samples Using RNA Sequencing Identifies Frequent Rearrangements Of FCHSD2

Venkata D Yellapantula, MS, Christopher Murray, Winnie Liang, PhD, Daniel Auclair, PhD, Joan Levy, PhD, John Carpten, PhD, Jonathan J Keats, PhD

Blood (2013) 122 (21): 534.

https://doi.org/10.1182/blood.V122.21.534.534

Published: 2013

Journal Articles

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Angela Baker, Esteban Braggio, Susanna Jacobus, Sungwon Jung, Dirk Larson, Terry Therneau, Angela Dispenzieri, Scott A. Van Wier, Gregory Ahmann, Joan Levy, Louise Perkins, Seungchan Kim, Kimberly Henderson, David Vesole, S. Vincent Rajkumar, Diane F. Jelinek, John Carpten, Rafael Fonseca

Blood (2013) 121 (16): 3147–3152.

https://doi.org/10.1182/blood-2012-07-443606

Published: 2013

Includes: Supplemental data

Journal Articles

DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription

Sungwon Jung, PhD, Kim Seungchan, Molly Gale, Rafael Fonseca, MD, John Carpten, Bodour Salhia

Blood (2012) 120 (21): 1285.

https://doi.org/10.1182/blood.V120.21.1285.1285

Published: 2012

Journal Articles

The Myeloma Genome in Drug Refractory Extra-Medullary Disease Identifies Mutations in Proteasome, Cereblon and Glucocorticoid Pathways

Jan Egan, PhD, Klaus Martin Kortuem, MD, Chang-Xin Shi, PhD, Jessica Schmidt, David Craig, PhD, John Carpten, PhD, Keith Stewart, MBA, MB, CHB

Blood (2012) 120 (21): 3968.

https://doi.org/10.1182/blood.V120.21.3968.3968

Published: 2012

Journal Articles

The Multiple Myeloma Research Foundation (MMRF) CoMMpass SM Study: A Longitudinal Study in Newly-Diagnosed Multiple Myeloma Patients to Assess Genomic Profiles, Immunophenotypes and Clinical Outcomes

Michael N. Needle, MD, Beverly Harrison, Carolyn Hoban, DSc, Pamela G. Kidd, MD, Scott Jewell, PhD, Thomas Monroe, PhD, Jonathan J Keats, PhD, John Carpten, PhD, Louise M. Perkins, PhD, Kenneth Anderson, MD, Sagar Lonial, MD

Blood (2012) 120 (21): 3980.

https://doi.org/10.1182/blood.V120.21.3980.3980

Published: 2012

Journal Articles

Analysis of Serial Patient Samples Reveals a Variety of Clonal Dynamics In Multiple Myeloma

Jonathan J Keats, PhD, Esteban Braggio, Scott Van Wier, Patrick Blackburn, BS, Angela Baker, Michael Barrett, John Carpten, Rafael Fonseca, Keith Stewart, MBA, MB, CHB, P. Leif Bergsagel

Blood (2010) 116 (21): 1923.

https://doi.org/10.1182/blood.V116.21.1923.1923

Published: 2010

Journal Articles

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

Michael A Chapman, Jean-Philippe Brunet, Jonathan J Keats, PhD, Angela Baker, Mazhar Adli, Anna C. Schinzel, Gregory Ahmann, BS, Harview Christina, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, PhD, Daniel Auclair, PhD, William C. Hahn, MD, PhD, Bradley E. Bernstein, MD, Leif Bergsagel, Rafael Fonseca, John Carpten, Jeffrey Trent, Todd R. Golub, MD

Blood (2009) 114 (22): 832.

https://doi.org/10.1182/blood.V114.22.832.832

Published: 2009

Journal Articles

Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk.

Jan Egan, PhD, Jonathan J Keats, PhD, P. Leif Bergsagel, MD, Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, John Carpten, A. Keith Stewart, MD

Blood (2009) 114 (22): 2810.

https://doi.org/10.1182/blood.V114.22.2810.2810

Published: 2009

Journal Articles

CpG Methylation Profiling in Multiple Myeloma.

Bodour Salhia, PhD, Angela Baker, PhD, Jonathan J Keats, PhD, Gregory Ahmann, BS, Daniel Auclair, PhD, Bunmi Mfuko, Louise M. Perkins, PhD, Joan Levy, PhD, Leif Bergsagel, MD, Rafael Fonseca, MD, John Carpten, PhD

Blood (2009) 114 (22): 604.

https://doi.org/10.1182/blood.V114.22.604.604

Published: 2009

Journal Articles

Loss of KDM6A/UTX Function Is a Common Event in a Mouse Model of Multiple Myeloma, Human Cell Lines and Patients.

Jonathan J Keats, PhD, Marta Chesi, PhD, Esteban Braggio, PhD, Stephan Palmer, Angela Baker, Michael Barrett, PhD, John Carpten, Rafael Fonseca, P. Leif Bergsagel, MD

Blood (2009) 114 (22): 606.

https://doi.org/10.1182/blood.V114.22.606.606

Published: 2009

Journal Articles

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Raoul Tibes, MD, PhD, Kevin T. McDonagh, MD, Lazaros Lekakis, MD, Neal Frazer, MD, Scott Mohrland, PhD, Bassett Dawn, RN, Reynaldo Garcia, RN, OCN, Katy Schroeder, RN, Vijayalakshmi Shanmugam, John Carpten, Daniel Von Hoff, MD, FACP, Thomas C. Shea, MD

Blood (2009) 114 (22): 1039.

https://doi.org/10.1182/blood.V114.22.1039.1039

Published: 2009

Journal Articles

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Soledad Molnar, MD, Victor J Jimenez Zepeda, Scott Van Wier, Esteban Braggio, Jonathan Keats, Michael Kuehl, Tammy Price-Troska, Greg Ahmann, Rachel Rempel, Kim Henderson, MD, S. Vincent Rajkumar, MD, Philip. R Greipp, MD, Daniel Auclair, John Carpten, Angela Baker, Keith Stewart, MD, P. Leif Bergsagel, MD, Wee Joo Chng, MD, Rafael Fonseca, MD

Blood (2008) 112 (11): 1663.

https://doi.org/10.1182/blood.V112.11.1663.1663

Published: 2008

Journal Articles

Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease

Michael A Chapman, Jean-Philippe Brunet, Angela Baker, Jonathan Keats, Gregory Ahmann, BS, Anna C Schinzel, PhD, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, PhD, Daniel Auclair, PhD, William C. Hahn, M.D., Ph.D, P. Leif Bergsagel, MD, Rafael Fonseca, MD, John Carpten, Jeffrey Trent, Todd R. Golub, MD

Blood (2008) 112 (11): 497.

https://doi.org/10.1182/blood.V112.11.497.497

Published: 2008

Journal Articles

RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines.

Travis J. Henry, PhD, Wee Joo Chng, MD, John Carpten, PhD, P. Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2489.

https://doi.org/10.1182/blood.V110.11.2489.2489

Published: 2007

Journal Articles

The Multiple Myeloma Research Consortium Genomics Initiative.

Jeffrey Trent, PhD, John Carpten, PhD, Michael Reich, PhD, Ted Liefeld, PhD, Jonathan Keats, PhD, Spyro Mousses, PhD, William Hahn, MD, PhD, Suzanne Trudel, MD, David Siegel, PhD, S. Vincent Rajkumar, MD, Melissa Alsina, MD, Paul Richardson, MD, Kenneth Anderson, MD, Daniel Auclair, PhD, Louise M. Perkins, PhD, Kathy Giusti, Rafael Fonseca, MD, Todd R. Golub, MD

Blood (2007) 110 (11): 2498.

https://doi.org/10.1182/blood.V110.11.2498.2498

Published: 2007

NARROW

HIV-Associated Diffuse Large B-Cell Lymphoma Shows Different Genomic Patterns between EBV-Positive and EBV-Negative Tumors

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

High Throughput Sequencing-Based Pathogen Discovery In Multiple Myeloma

Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles

Gene Expression Profiling Of Multiple Myeloma Samples Using RNA Sequencing Identifies Frequent Rearrangements Of FCHSD2

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription

The Myeloma Genome in Drug Refractory Extra-Medullary Disease Identifies Mutations in Proteasome, Cereblon and Glucocorticoid Pathways

The Multiple Myeloma Research Foundation (MMRF) CoMMpass SM Study: A Longitudinal Study in Newly-Diagnosed Multiple Myeloma Patients to Assess Genomic Profiles, Immunophenotypes and Clinical Outcomes

Analysis of Serial Patient Samples Reveals a Variety of Clonal Dynamics In Multiple Myeloma

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk.

CpG Methylation Profiling in Multiple Myeloma.

Loss of KDM6A/UTX Function Is a Common Event in a Mouse Model of Multiple Myeloma, Human Cell Lines and Patients.

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease

RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines.

The Multiple Myeloma Research Consortium Genomics Initiative.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only